Utilizing the gene expression profiling interactive analysis server (GEPIA2)46, we assessed the expression pattern of SLC16A1 and SLC16A3 in cancer patients in comparison to normal samples (TCGA-matching and the Genotype-Tissue Expression project47) (Fig. 7a, b). The gene discussed is SLC16A1; the disease is cancer.